{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:48:26Z","timestamp":1778698106000,"version":"3.51.4"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1911,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> A recent report suggesting mitochondrial dysfunction among eight HIV\u2010exposed but uninfected children exposed perinatally to nucleoside reverse transcriptase inhibitors (NRTIs) prompted a review within the Perinatal AIDS Collaborative Transmission Study (PACTS). A standardized retrospective review was conducted of 118 deaths at &lt;5 years. Deaths were classified as unrelated to mitochondrial dysfunction (Class 1), unlikely related (Class 2), possibly related (Class 3), or likely related or proven (Class 4). Among 35 deaths recorded in HIV\u2010uninfected or indeterminate children, none were classified in either Class 2, 3, or 4. We also reviewed signs or symptoms consistent with possible mitochondrial dysfunction among 1,954 living uninfected children. Only one child was in Class 3 and two siblings were in Class 2; none had perinatal antiretroviral drug exposure. We found no evidence indicating that uninfected infants exposed to perinatal NRTIs died of mitochondrial disorders or that living exposed children had symptoms of mitochondrial dysfunction.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb05491.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T20:16:17Z","timestamp":1279656977000},"page":"212-221","source":"Crossref","is-referenced-by-count":48,"title":["Lack of Evidence of Mitochondrial Dysfunction in the Offspring of HIV\u2010Infected Women: Retrospective Review of Perinatal Exposure to Antiretroviral Drugs in the Perinatal AIDS Collaborative Transmission Study"],"prefix":"10.1111","volume":"918","author":[{"given":"MARC","family":"BULTERYS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEVEN","family":"NESHEIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELAINE J.","family":"ABRAMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAUL","family":"PALUMBO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN","family":"FARLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARGARET","family":"LAMPE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARY GLENN","family":"FOWLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"THE PERINATAL SAFETY REVIEW WORKING GROUP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"issue":"2","key":"e_1_2_6_2_2","first-page":"1","article-title":"Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV\u20101 for maternal health and for reducing perinatal HIV\u20101 transmission in the United States","volume":"47","author":"Centers for Disease Control and Prevention.","year":"1998","journal-title":"Morbid. Mortal. Wkly. Rep."},{"issue":"5","key":"e_1_2_6_3_2","first-page":"39","article-title":"Guidelines for the use of anti\u2010retroviral agents in HIV\u2010infected adults and adolescents","volume":"47","author":"Centers for Disease Control and Prevention.","year":"1998","journal-title":"Morbid. Mortal. Wkly. Rep."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.2.151"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199904150-00008"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-417"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199814000-00004"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07219-0"},{"key":"e_1_2_6_9_2","unstructured":"Perinatal Safety Review Working Group. 2000. Nucleoside exposure in the off\u2010spring of HIV\u2010infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before five years of age in five United States cohorts. Submitted to Lancet."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199803000-00008"},{"key":"e_1_2_6_11_2","first-page":"289","article-title":"Trends in zidovudine prescription for pregnant women infected with HIV","volume":"18","author":"Lansky A.","year":"1998","journal-title":"J. AIDS Hum. Retrovir."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.6.531"},{"key":"e_1_2_6_13_2","unstructured":"Smith M. for the Perinatal Safety Review Working Group. 1999. Presented at the Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants in Montreal Canada September 1\u20106."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70203-0"},{"key":"e_1_2_6_15_2","unstructured":"Workshop on Detection of Potential Toxicities following Perinatal Exposure to Antiretrovirals. 1999. Report from the Workshop on Detection of Potential Toxicities following Perinatal Exposure to Antiretrovirals. Office of AIDS Research National Institutes of Health. Bethesda Maryland January 19\u201020."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05491.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb05491.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T23:27:28Z","timestamp":1695684448000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb05491.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb05491.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05491.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}